National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care von El‐Akel, W., El‐Sayed, M. H., El Kassas, M., El‐Serafy, M., Khairy, M., Elsaeed, K., Kabil, K., Hassany, M., Shawky, A., Yosry, A., Shaker, M. K., ElShazly, Y., Waked, I., Esmat, G., Doss, W.

Volltext

Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt von Elsharkawy, A., Fouad, R., El Akel, W., El Raziky, M., Hassany, M., Shiha, G., Said, M., Motawea, I., El Demerdash, T., Seif, S., Gaballah, A., El Shazly, Y., Makhlouf, M. A. M., Waked, I., Abdelaziz, A. O., Yosry, A., El Serafy, M., Thursz, M., Doss, W., Esmat, G.

Volltext

Prevalence of thyroid dysfunction among 21672 Egyptian patients with chronic HCV genotype IV von Eletreby, R, Said, M, Abdellatif, Z, Saad, Y, El Serafy, M, Yosry, A, Waked, I, Esmat, G, Doss, W

Volltext

Validation of the role of FIB-4 and APRI in the assessment of hepatic fibrosis and prediction of risky varices in Egyptian patients with chronic hepatitis C (genotype 4) von El-Nahaas, S.M, Said, M, Soliman, Z.A, Saad, Y, El-Serafy, M, Yosry, A, Waked, I, Esmat, G, Doss, W

Volltext

Efficacy and Safety of Direct Acting Antiviral Therapy for HCV Genotype 4 in Egypt; Multicenter Real Life Experience von Serafy, M, Said, M, Esmat, G, Yosry, A, Waked, I, Alakel, W, Elsayed, M.H, Kabil, K, Hassany, M, Elraziky, M, Alkeliny, N, Anis, M, Doss, W

Volltext

Real-Life Results of Sofosbuvir Based Therapy for Egyptian Patients with Hepatitis C and Advanced Fibrosis-Cirrhosis von Doss, W, Esmat, G, El-Serafy, M, El-Akel, W, Yosry, A, El-Sayed, M, Hassany, M, El-Kassas, M, Kabil, K, Waked, I

Volltext

Transcriptional Response of MxA, PKR and SOCS3 to Interferon-Based Therapy in HCV Genotype 4-Infected Patients and Contribution of p53 to Host Antiviral Response von Hamdi, N., El-Akel, W., El-Serafy, M., Esmat, G., Sarrazin, C., Abdelaziz, A.I.

Volltext

Management of Hearing Impairment in Children von Morsy , Tosson A, El-Bahnasawy , Mamdouh M, El-Serafy , Gamal M

Volltext

Factors associated with nonresponse in a cohort of 10655 chronic hepatitis C patients treated with direct acting antivirals von Shousha, H., Said, M., Saleh, D., Saad, Y., Dabees, H., El-Serafy, M., Elsaees, K., Elshazly, Y.

Volltext

THU-288 - Factors associated with nonresponse in a cohort of 10655 chronic hepatitis C patients treated with direct acting antivirals von Shousha, H., Said, M., Saleh, D., Saad, Y., Dabees, H., El-Serafy, M., Elsaees, K., Elshazly, Y.

Volltext

THU-330 - Real-life experience of ritonavir-boosted paritaprevir, ombitasvir plus ribavirin for treatment of HCV-GT4 in Egyptian patients with severe renal impairment von Omar, H., Said, M., Abdellatif, Z., Saad, Y., Dabes, H., Hamed, S., El-Serafy, M., Elsaeed, K., Elshazly, Y.

Volltext

Real-life experience of ritonavir-boosted paritaprevir, ombitasvir plus ribavirin for treatment of HCV-GT4 in Egyptian patients with severe renal impairment von Omar, H., Said, M., Abdellatif, Z., Saad, Y., Dabes, H., Hamed, S., El-Serafy, M., Elsaeed, K., Elshazly, Y.

Volltext

SAT-192 - Prevalence of thyroid dysfunction among 21672 Egyptian patients with chronic HCV genotype IV von Eletreby, R., Said, M., Abdellatif, Z., Saad, Y., El Serafy, M., Yosry, A., Waked, I., Esmat, G., Doss, W.

Volltext

SAT-196 - Validation of the role of FIB-4 and APRI in the assessment of hepatic fibrosis and prediction of risky varices in Egyptian patients with chronic hepatitis C (genotype 4) von El-Nahaas, S.M., Said, M., Soliman, Z.A., Saad, Y., El-Serafy, M., Yosry, A., Waked, I., Esmat, G., Doss, W.

Volltext

Outcome of Living Donor Liver Transplantation for Egyptian Patients With Hepatitis C (Genotype 4)-Related Cirrhosis von Yosry, A, Esmat, G, El-Serafy, M, Omar, A, Doss, W, Said, M, Abdel-Bary, A, Hosny, A, Marawan, I, El-Malt, O, Kamel, R.R, Hatata, Y, Ghali, A, Sabri, H, Kamel, S, El-Gbaly, H, Tanaka, K

Volltext

SAT-204 - Efficacy and Safety of Direct Acting Antiviral Therapy for HCV Genotype 4 in Egypt; Multicenter Real Life Experience von Serafy, M., Said, M., Esmat, G., Yosry, A., Waked, I., Alakel, W., Elsayed, M.H., Kabil, K., Hassany, M., Elraziky, M., Alkeliny, N., Anis, M., Doss, W.

Volltext

SAT-165 - Real-Life Results of Sofosbuvir Based Therapy for Egyptian Patients with Hepatitis C and Advanced Fibrosis-Cirrhosis von Doss, W., Esmat, G., El-Serafy, M., El-Akel, W., Yosry, A., El-Sayed, M., Hassany, M., El-Kassas, M., Kabil, K., Waked, I.

Volltext

Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs von Anwar, Wagida A., Salama, Somaia I., Serafy, Mostafa M.EI, Hemida, Samia A., Hafez, Ahmed S.

Volltext

Hepatitis C virus infection and global kidney health: the consensus proceedings of the International Federation of Kidney Foundations von Saadi, Gamal, Kalantar-Zadeh, Kamyar, Almasio, Piero, Ashuntantang, Gloria, Barsoum, Rashad, Bruchfeld, Annette, Doss, Wahid, ElFishawy, Hussein, Raziky, Maissa El, El-Serafy, Magdy, Fabrizi, Fabrizio, Hafez, Hani, Hassaballa, May, Hammady, Mona M R, Sheishaa, Hussein, Abdelaziz, Tarek S, Ulasi, Ifeoma, Zakharova, Elena, Jadoul, Michel

Volltext

A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorect... von Bouzid, K., Khalfallah, S., Tujakowski, J., Piko, B., Purkalne, G., Plate, S., Padrik, P., Serafy, M., Pshevloutsky, E. M., Boussard, B.

Volltext